Toxicology Services Advisory Board

Michael A. Dorato

  • Executive Vice President
  • Toxicology Services

Dr. Dorato has over 35 years of experience, as a researcher and global leader of safety and efficacy in the pharmaceutical and CRO industries. Prior to joining Smithers, he was the Vice-President and CSO, Global Discovery Services (Covance) and Executive Director, Toxicology (Eli Lilly and Co.). In these positions he led global organizations in safety and efficacy lead optimization, investigative and regulatory toxicology, discovery and late phase pathology, animal welfare, molecular and anatomical imaging, in vivo pharmacology, veterinary medicine and model development. Dr. Dorato has more than 100 scientific publications/presentations.

Stephen B. Harris

President of Stephen B. Harris Group in San Diego, CA, since September 1982, Dr. Harris has over 40 years of professional experience in developmental and reproductive toxicology and has been an independent consultant for over 30 years. Since 1985, he has held several teaching appointments at San Diego State University, Stanford University, and National University in the areas of developmental and reproductive toxicology. He continues to mentor graduate students, and supervises thesis research, as an Adjunct Associate Professor in the Graduate School of Public Health at San Diego State University. Dr. Harris interfaces with both national and international regulatory agencies. He is a Managing Editor for Food and Chemical Toxicology, on the Editorial Board of the International Journal of Toxicology and the Journal of Environmental Science and Health, Part C, Environmental Carcinogenesis and Ecotoxicology Reviews (ECER). Dr. Harris was President of the American College of Toxicology (2006-2007). Currently he is a Councilor of the Teratology Society (2012-2015) and Fellow of the Academy of Toxicological Sciences and Society of Biology.

Steve Snyder

  • President of Outsourcing Support Services

President of Outsourcing Support Services, a consulting company that specializes in non-clinical study monitoring and research operations improvements, Mr. Snyder has over 35 years of industry experience in non-clinical toxicology including positions at Charles River Laboratories, Wyeth, McNeil Pharmaceutical, and Eli Lilly, where he managed the general toxicology component. At Charles River, he became familiar with the inner workings of a CRO with responsibilities in marketing, business development, and project management. Mr. Snyder has been consulting for 12 years with clients ranging from large pharmaceutical organizations to virtual biotechnology companies and consulting firms. He is familiar with the management teams at, and the capabilities of, most non-clinical CROs. He leverages his strong background in regulatory compliance and his years of experience to mitigate the risk of outsourcing for his clients, and is regarded as an industry expert in non-clinical outsourcing and research operations, having written extensively on these topics in the trade publication Contract Pharma and his own blog on LinkedIn.